Antibody Cocktails
- All
- News
- Videos
-
No Anti-Covid Drug, Antibody Cocktail Therapy In Revised Covid Guidelines
According to the revised guidelines, there is no evidence of injectable steroids in those who doesn't require oxygen supplementation or in continuation, after discharge, because that can lead to a risk of secondary infection like mucormycosis.
-
AstraZeneca Says Its Antibody Cocktail Prevents Covid In High-Risk Groups
AstraZeneca Plc's Covid-19 antibody cocktail was found to be 77% effective in preventing symptomatic Covid-19 in high-risk people in a key trial that could expand the range of drugs available to vulnerable groups.
-
As Delta Surges, Demand Explodes For Antibody Cocktails. This Is Why
Outside, in letters a foot tall, the wall of the trailer reads: "GET TESTED. GET TREATED. CRUSH COVID."
-
Antibody Drug Cuts Deaths From Some Severe Covid Patients: Study
A cocktail of synthetic antibodies reduces deaths among severe Covid patients who are unable to mount a strong immune response, results from a major clinical trial showed Wednesday.
-
AstraZeneca's Antibody Cocktail Fails to Prevent Covid: Study
AstraZeneca Plc's antibody cocktail was only 33% effective at preventing COVID-19 symptoms in people who had been exposed to the virus, failing a study that was key to the drugmaker's pandemic push.
-
"Symptoms Gone In A Day": Doctor On Antibody Cocktail To 40 In Hyderabad
As many as 40 Covid patients have taken a single-dose drug cocktail of monoclonal antibodies at Hyderabad's Asian Institute of Gastroenterology. "In 24 hours, they recovered from clinical symptoms like fever, malaise etc," said top doctor.
-
Delhi's LNJP Hospital Begins Free Antibody Cocktail Therapy For Covid Patients
The Monoclonal Antibody Cocktail used to treat mild to moderate "high risk" Covid patients is now available at Delhi's Lok Nayak Jai Prakash Narayan Hospital (LNJP) for free.
-
Antibody Cocktail Therapy Begins At Delhi's Sir Ganga Ram Hospital
Delhi's premier Ganga Ram Hospital has started administration of Monoclonal Antibody Cocktail from June 1. The new therapy -- which carries a lot of hope for Covid patients -- is a combination of Casirivimab and Imdevimab.
-
Cocktail Antibodies Injection Used First Time In Andhra Pradesh
A hospitalin Andhra Pradesh's Guntur district has administered cocktail antibodies injection 'Regeneron' to two patients. This is the first time the cocktail antibodies injection was used in Andhra Pradesh.
-
Zydus Cadila Seeks Human Trial Approval For COVID-19 Antibody Cocktail
Zydus Cadila has sought regulatory approval for clinical trials of its antibody cocktail to treat mild COVID-19, as India grapples with a shortage of medicines and vaccines needed to effectively tackle a devastating second wave of the pandemic.
-
First Covid Patient Treated With 'Antibody Cocktail' In India Discharged
The first COVID-19 patient in India who was treated with a monoclonal antibodies cocktail was discharged from a hospital in Haryana today, a day after he was administered the jab.
-
Cipla Lauches Antibody Cocktail For Covid-19 Treatment; Shares Subdued
"Roche India and Cipla today announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India," Cipla said in a regulatory filing to the stock exchanges
-
Covid Antibody Cocktail, Used To Treat Donald Trump, Comes To India. It Costs...
Drug major Roche India on Monday announced the launch of its first batch of antibody cocktail against COVID-19 in India. The antibody cocktail -- Casirivimab and Imdevimab -- is priced at Rs 59,750 per dose. Roche's antibody cocktail was given to for
-
Antibody Cocktail Used In Covid Treatment Gets Emergency Use Approval
Drug firm Roche India on Wednesday said it has received Emergency Use Authorisation (EUA) from the Central Drugs Standards Control Organisation (CDSCO) for Roche's investigational antibody cocktail used in the treatment of COVID-19.
-
Astrazeneca Starts Trial Of COVID-19 Antibody Treatment
British drugmaker AstraZeneca has begun testing an antibody-based cocktail for the prevention and treatment of COVID-19, adding to recent signs of progress on possible medical solutions to the disease caused by the novel coronavirus.
-
No Anti-Covid Drug, Antibody Cocktail Therapy In Revised Covid Guidelines
According to the revised guidelines, there is no evidence of injectable steroids in those who doesn't require oxygen supplementation or in continuation, after discharge, because that can lead to a risk of secondary infection like mucormycosis.
-
AstraZeneca Says Its Antibody Cocktail Prevents Covid In High-Risk Groups
AstraZeneca Plc's Covid-19 antibody cocktail was found to be 77% effective in preventing symptomatic Covid-19 in high-risk people in a key trial that could expand the range of drugs available to vulnerable groups.
-
As Delta Surges, Demand Explodes For Antibody Cocktails. This Is Why
Outside, in letters a foot tall, the wall of the trailer reads: "GET TESTED. GET TREATED. CRUSH COVID."
-
Antibody Drug Cuts Deaths From Some Severe Covid Patients: Study
A cocktail of synthetic antibodies reduces deaths among severe Covid patients who are unable to mount a strong immune response, results from a major clinical trial showed Wednesday.
-
AstraZeneca's Antibody Cocktail Fails to Prevent Covid: Study
AstraZeneca Plc's antibody cocktail was only 33% effective at preventing COVID-19 symptoms in people who had been exposed to the virus, failing a study that was key to the drugmaker's pandemic push.
-
"Symptoms Gone In A Day": Doctor On Antibody Cocktail To 40 In Hyderabad
As many as 40 Covid patients have taken a single-dose drug cocktail of monoclonal antibodies at Hyderabad's Asian Institute of Gastroenterology. "In 24 hours, they recovered from clinical symptoms like fever, malaise etc," said top doctor.
-
Delhi's LNJP Hospital Begins Free Antibody Cocktail Therapy For Covid Patients
The Monoclonal Antibody Cocktail used to treat mild to moderate "high risk" Covid patients is now available at Delhi's Lok Nayak Jai Prakash Narayan Hospital (LNJP) for free.
-
Antibody Cocktail Therapy Begins At Delhi's Sir Ganga Ram Hospital
Delhi's premier Ganga Ram Hospital has started administration of Monoclonal Antibody Cocktail from June 1. The new therapy -- which carries a lot of hope for Covid patients -- is a combination of Casirivimab and Imdevimab.
-
Cocktail Antibodies Injection Used First Time In Andhra Pradesh
A hospitalin Andhra Pradesh's Guntur district has administered cocktail antibodies injection 'Regeneron' to two patients. This is the first time the cocktail antibodies injection was used in Andhra Pradesh.
-
Zydus Cadila Seeks Human Trial Approval For COVID-19 Antibody Cocktail
Zydus Cadila has sought regulatory approval for clinical trials of its antibody cocktail to treat mild COVID-19, as India grapples with a shortage of medicines and vaccines needed to effectively tackle a devastating second wave of the pandemic.
-
First Covid Patient Treated With 'Antibody Cocktail' In India Discharged
The first COVID-19 patient in India who was treated with a monoclonal antibodies cocktail was discharged from a hospital in Haryana today, a day after he was administered the jab.
-
Cipla Lauches Antibody Cocktail For Covid-19 Treatment; Shares Subdued
"Roche India and Cipla today announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India," Cipla said in a regulatory filing to the stock exchanges
-
Covid Antibody Cocktail, Used To Treat Donald Trump, Comes To India. It Costs...
Drug major Roche India on Monday announced the launch of its first batch of antibody cocktail against COVID-19 in India. The antibody cocktail -- Casirivimab and Imdevimab -- is priced at Rs 59,750 per dose. Roche's antibody cocktail was given to for
-
Antibody Cocktail Used In Covid Treatment Gets Emergency Use Approval
Drug firm Roche India on Wednesday said it has received Emergency Use Authorisation (EUA) from the Central Drugs Standards Control Organisation (CDSCO) for Roche's investigational antibody cocktail used in the treatment of COVID-19.
-
Astrazeneca Starts Trial Of COVID-19 Antibody Treatment
British drugmaker AstraZeneca has begun testing an antibody-based cocktail for the prevention and treatment of COVID-19, adding to recent signs of progress on possible medical solutions to the disease caused by the novel coronavirus.
